Kumar, V., & Panda, B. K. (2017). CAN COST OF PHARMACOLOGICAL THROMBOLYTIC THERAPY BE A MEDICATION MANAGEMENT STRATEGY FOR ACUTE CORONARY SYNDROME?. Asian Journal of Pharmaceutical and Clinical Research, 10(3), 363-366. https://doi.org/10.22159/ajpcr.2017.v10i3.16308